European Network of Vaccine Development and Research

Informazioni relative al progetto

TRANSVAC

ID dell’accordo di sovvenzione: 228403

Progetto chiuso

Data di avvio 1 Ottobre 2009

Data di completamento 30 Settembre 2013

Finanziato da

• Specific Programme "Capacities": Research infrastructures

Costo totale € 11 871 094,27

Contributo UE € 9 899 999,00

Coordinato da

EUROPEAN VACCINE INITIATIVE EWIV
Germany

Obiettivo

The TRANSVAC infrastructure will accelerate the pharmaceutical and clinical development of promising vaccine candidates by bringing the gap between academic research and clinical trials through carefully managing the advancement of promising vaccine candidates from preclinical animal models to early proof-of-principle studies in humans. Although expertise already exists within Europe spanning different disease types, there is currently very limited coordination between vaccine R&D groups, assay developers and vaccine producers. Unarguably, fragmentation of expertise and facilities has slowed, and in some instances distinctly impeded, the development and validation of promising vaccine candidates. To address these challenges the European vaccine development community needs to establish a collaborative vaccine development infrastructure based on shared visions and goals. The European Vaccine Initiative (EVI) and the Tuberculosis Vaccine Integrated (TBVI) Project have each demonstrated significant success in creating the know-how and infrastructures to enable the advancement of European vaccine development. In order to sustain the momentum generated by EVI and TBVI these successes will be built-upon to create an infrastructure driven by EVI, in which all stakeholders commit to sharing facilities and knowhow on vaccine development. This consortium (TRANSVAC) will comprise major European stakeholders with expertise, resources and facilities for each stage of vaccine development, from the scientific community as well as vaccine developers. Each stakeholder can add to what EVI and TBVI have already established by adding their own expertise to the TRANSVAC long term strategy. TRANSVAC will be the European driving force for vaccine development, and will be accessible to any interested parties. This consortium will initiate a new era in the innovative, harmonised and rapid development of accessible and efficacious vaccines for Europe and the rest of the world.

Campo scientifico

• medical and health sciences › clinical medicine › pneumology › tuberculosis
• medical and health sciences › basic medicine › pharmacology and pharmacy › pharmaceutical drugs › vaccines

Programma(i)

• FP7-INFRASTRUCTURES - Specific Programme "Capacities": Research infrastructures

Argomento(i)

• INFRA-2008-1.1.2 - Targeted approach: Integrated Activities to support the specific needs of thematic priority areas

Invito a presentare proposte

FP7-INFRASTRUCTURES-2008-1
Vedi altri progetti per questo bando

Meccanismo di finanziamento

CP-CSA-Infra - Combination of CP and CSA

Coordinatore

EUROPEAN VACCINE INITIATIVE EWIV

• Contributo UE: € 2 116 215,72
• Indirizzo: VOSSSTRASSE 2 GEB 4040 ; 69115 Heidelberg ; Germania
• Regione: Baden-Württemberg › Karlsruhe › Heidelberg, Stadtkreis
• Tipo di attività: Research Organisations
• Contatto amministrativo: Odile Leroy (Dr.)
• Costo totale: Nessun dato

Partecipanti (14)

STICHTING BIOMEDICAL PRIMATE RESEARCH CENTER

Paesi Bassi

• Contributo UE: € 1 404 380,36
• Indirizzo: LANGE KLEIWEG 161 ; 2288 GJ Rijswijk Zh
• Regione: West-Nederland › Zuid-Holland › Agglomeratie ’s-Gravenhage
• Tipo di attività: Research Organisations
• Contatto amministrativo: Willem Slingerland (Mr.)
• Costo totale: Nessun dato

HELMHOLTZ-ZENTRUM FUR INFEKTIONSFORSCHUNG GMBH

Germania

• Contributo UE: € 577 460,33
• Indirizzo: INHOFFENSTRASSE 7 ; 38124 Braunschweig
• Regione: Niedersachsen › Braunschweig › Braunschweig, Kreisfreie Stadt
• Tipo di attività: Research Organisations
• Contatto amministrativo: Michael Straetz (Dr.)
• Costo totale: Nessun dato

Serum Life Science Europe GmbH

Germania

• Contributo UE: € 23 100,00
• Indirizzo: Ahrensburger Straße 1 ; 30659 HANNOVER
• Regione: Niedersachsen › Hannover › Region Hannover
• Tipo di attività: Private for-profit entities (excluding Higher or Secondary Education Establishments)
• Contatto amministrativo: Leander Grode (Dr.)
• Costo totale: Nessun dato

LIONEX GMBH

Germania

• Contributo UE: € 959 975,00
• Indirizzo: Salzdahlumer Strasse 196 ; 38126 Braunschweig
• Regione: Niedersachsen › Braunschweig › Braunschweig, Kreisfreie Stadt
• Tipo di attività: Private for-profit entities (excluding Higher or Secondary Education Establishments)
• Contatto amministrativo: Mahavir Singh (Prof.)
• Costo totale: Nessun dato

ID-LELYSTAD, INSTITUUT VOOR DIERHOUDERIJ EN DIERGEZONDHEID B.V.

Partecipazione conclusa

Paesi Bassi

• Contributo UE: € 86 615,36
• Indirizzo: Edelhertweg 15 ; 8219PH LELYSTAD
• Tipo di attività: Research Organisations
• Contatto amministrativo: Jelle Thole (Dr.)
• Costo totale: Nessun dato

HEALTH PROTECTION AGENCY HPA

Regno Unito

• Contributo UE: Nessun dato
• Indirizzo: BUCKINGHAM PALACE ROAD 151 ; SW1W 9SZ London
• Tipo di attività: Research Organisations
• Contatto amministrativo: Steve White (Dr.)
• Costo totale: Nessun dato

MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV

Germania

• Contributo UE: € 979 494,97
• Indirizzo: HOFGARTENSTRASSE 8 ; 80539 Munchen
• Regione: Bayern › Oberbayern › München, Kreisfreie Stadt
• Tipo di attività: Research Organisations
• Contatto amministrativo: Stefan H.E. Kaufmann (Prof.)
• Costo totale: Nessun dato

UNIVERSITAET REGENSBURG

Germania

• Contributo UE: € 229 006,82
• Indirizzo: UNIVERSITATSSTRASSE 31 ; 93053 Regensburg
• Regione: Bayern › Oberpfalz › Regensburg, Kreisfreie Stadt
• Tipo di attività: Higher or Secondary Education Establishments
• Contatto amministrativo: Christian Blomeyer (Dr.)
• Costo totale: Nessun dato

LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE ROYAL CHARTER

Regno Unito

• Contributo UE: € 339 000,00
• Indirizzo: KEPPEL STREET ; WC1E 7HT London
• Regione: London › Inner London — West › Camden and City of London
• Tipo di attività: Higher or Secondary Education Establishments
• Contatto amministrativo: Penny Ireland (Ms.)
• Costo totale: Nessun dato

THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD

Regno Unito

• Contributo UE: € 900 495,00
• Indirizzo: WELLINGTON SQUARE UNIVERSITY OFFICES ; OX1 2JD Oxford
• Regione: South East (England) › Berkshire, Buckinghamshire and Oxfordshire › Oxfordshire
• Tipo di attività: Higher or Secondary Education Establishments
• Contatto amministrativo: Gary Strickland (Mr.)
• Costo totale: Nessun dato

UNIVERSITE DE LAUSANNE

Svizzera

• Contributo UE: € 656 775,56
• Indirizzo: QUARTIER UNIL CENTRE - BATIMENT UNICENTRE ; 1015 LAUSANNE
• Regione: Schweiz/Suisse/Svizzera › Région lémanique › Vaud
• Tipo di attività: Higher or Secondary Education Establishments
• Contatto amministrativo: Gerard Mareine (Mr.)
• Costo totale: Nessun dato

STICHTING TUBERCULOSIS VACCINE INITIATIVE

Paesi Bassi

• Contributo UE: € 85 107,28
• Indirizzo: Runderweg 6 ; 8219 PK LELYSTAD
• Regione: Oost-Nederland › Flevoland › Flevoland
• Tipo di attività: Other
• Contatto amministrativo: Jelle Thole (Dr.)
• Costo totale: Nessun dato

STICHTING WAGENINGEN RESEARCH

Paesi Bassi

• Contributo UE: € 586 018,06
• Indirizzo: DROEVENDAALSESTEEG 4 ; 6708 PB Wageningen
• Regione: Oost-Nederland › Gelderland › Veluwe
• Tipo di attività: Research Organisations
• Contatto amministrativo: Norbert Stockhofe (Dr.)
• Costo totale: Nessun dato

Department of Health

Regno Unito

• Contributo UE: € 956 354,54
• Indirizzo: Quarry House, Quarry Hill ; LS2 7UE Leeds
• Regione: Yorkshire and the Humber › West Yorkshire › Leeds
• Tipo di attività: Research Organisations
• Contatto amministrativo: Cathy Rowe (Mrs.)
• Costo totale: Nessun dato